Pune-based Institute
- All
- News
- Videos
-
COVID-19 Virus Piggybacks Only Black Carbon Emission: Study
A new study conducted by the Pune-based Indian Institute of Tropical Meteorology suggests that COVID-19 virus piggybacks only black carbon emitted during biomass burning and not all PM2.5 particles.
-
Serum Institute's Adar Poonawalla To Get Y Category Security Cover
Pune-based Serum Institute chief Adar Poonawalla will be provided "Y category" security across the country.The Union Home Ministry issued orders regarding this today after conducting a detailed threat assessment, sources said.
-
On Plea To Declare Covishield "Unsafe", High Court Notice To Centre
The Madras High Court has issued a notice to the central government over a petition to declare the Pune-based Serum Institute of India's "Covishield" unsafe.
-
Fire At Vaccine Firm Serum Institute Of India An "Accident": Sharad Pawar
The fire at the premises of Serum Institute of India (SII) was an "accident" and there is absolutely no doubt about the integrity of scientists working with the Pune-based vaccine major, NCP president Sharad Pawar said today.
-
With 12,584 COVID-19 Cases, India Sees Lowest Daily Rise Since Mid-June: 10 Points
India saw the lowest single-day jump in coronavirus cases in the last 24 hours since mid-June with 12,584 fresh infections taking the tally to 1,04,79,179, the government data this morning showed. 167 deaths linked to the highly infectious disease since yesterday took the total number of deaths to 1,51,327. As the country prepares for the vaccine r...
-
"Happy New Year, All Risks Paid Off": Adar Poonawalla On Vaccine Approval
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country's drug regulator cleared its Covishield vaccine for emergency approval in India.Mr Poonawalla reiteratedthat the Covishieldvaccine -- developed by Serum Institute of India in pa...
-
India's Wait Over, Drug Regulator Says Covid Vaccines Cleared "110% Safe"
Two vaccines for coronavirus, Oxford University's Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech's Covaxin, received emergency approval from the country's drug regulator on Sunday. "We'll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe," Drug Controller G...
-
Prime Minister Narendra Modi To Visit Serum Institute Of India In Pune On November 28
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said on Thursday.
-
PM Modi To Visit Serum Institute That's Making Oxford Vaccine, On Saturday
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said today.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
When Will Covid Vaccine Be Available? What Adar Poonawalla Told NDTV
The Oxford coronavirus vaccine produced by India's Serum Institute could be ready as early as December and the first batch of 100 million doses should be available by the second or third quarter of 2021, Adar Poonawalla, chief of the Pune-based company told NDTV on Wednesday.
-
Covishield Vaccine: Phase II Human Trial Of Oxford COVID-19 Vaccine Candidate Begins In Pune
The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the Pune-based Serum Institute of India (SII), began at a medical college and hospital in the city today.
-
Phase 2 Trial Of Oxford COVID-19 Vaccine Candidate To Begin Today
The phase 2 human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to begin today.
-
Pune Institute Wins Smart India Hackathon 2020
Pune-based Defence Institute of Advanced Technology (DIAT) has won the first prize in the Smart India Hackathon (SIH) 2020, a national-level digital product building competition.
-
Pune Institute Student Reveals Violet Flaring At The Centre Of Black Hole
A team of astronomers, led by John Paice who is a student at Pune-based Inter-University Centre for Astronomy & Astrophysics (IUCAA), has created a high frame-rate movie of a growing black hole system at a level of detail never seen before.
-
COVID-19 Virus Piggybacks Only Black Carbon Emission: Study
A new study conducted by the Pune-based Indian Institute of Tropical Meteorology suggests that COVID-19 virus piggybacks only black carbon emitted during biomass burning and not all PM2.5 particles.
-
Serum Institute's Adar Poonawalla To Get Y Category Security Cover
Pune-based Serum Institute chief Adar Poonawalla will be provided "Y category" security across the country.The Union Home Ministry issued orders regarding this today after conducting a detailed threat assessment, sources said.
-
On Plea To Declare Covishield "Unsafe", High Court Notice To Centre
The Madras High Court has issued a notice to the central government over a petition to declare the Pune-based Serum Institute of India's "Covishield" unsafe.
-
Fire At Vaccine Firm Serum Institute Of India An "Accident": Sharad Pawar
The fire at the premises of Serum Institute of India (SII) was an "accident" and there is absolutely no doubt about the integrity of scientists working with the Pune-based vaccine major, NCP president Sharad Pawar said today.
-
With 12,584 COVID-19 Cases, India Sees Lowest Daily Rise Since Mid-June: 10 Points
India saw the lowest single-day jump in coronavirus cases in the last 24 hours since mid-June with 12,584 fresh infections taking the tally to 1,04,79,179, the government data this morning showed. 167 deaths linked to the highly infectious disease since yesterday took the total number of deaths to 1,51,327. As the country prepares for the vaccine r...
-
"Happy New Year, All Risks Paid Off": Adar Poonawalla On Vaccine Approval
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country's drug regulator cleared its Covishield vaccine for emergency approval in India.Mr Poonawalla reiteratedthat the Covishieldvaccine -- developed by Serum Institute of India in pa...
-
India's Wait Over, Drug Regulator Says Covid Vaccines Cleared "110% Safe"
Two vaccines for coronavirus, Oxford University's Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech's Covaxin, received emergency approval from the country's drug regulator on Sunday. "We'll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe," Drug Controller G...
-
Prime Minister Narendra Modi To Visit Serum Institute Of India In Pune On November 28
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said on Thursday.
-
PM Modi To Visit Serum Institute That's Making Oxford Vaccine, On Saturday
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said today.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
When Will Covid Vaccine Be Available? What Adar Poonawalla Told NDTV
The Oxford coronavirus vaccine produced by India's Serum Institute could be ready as early as December and the first batch of 100 million doses should be available by the second or third quarter of 2021, Adar Poonawalla, chief of the Pune-based company told NDTV on Wednesday.
-
Covishield Vaccine: Phase II Human Trial Of Oxford COVID-19 Vaccine Candidate Begins In Pune
The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the Pune-based Serum Institute of India (SII), began at a medical college and hospital in the city today.
-
Phase 2 Trial Of Oxford COVID-19 Vaccine Candidate To Begin Today
The phase 2 human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to begin today.
-
Pune Institute Wins Smart India Hackathon 2020
Pune-based Defence Institute of Advanced Technology (DIAT) has won the first prize in the Smart India Hackathon (SIH) 2020, a national-level digital product building competition.
-
Pune Institute Student Reveals Violet Flaring At The Centre Of Black Hole
A team of astronomers, led by John Paice who is a student at Pune-based Inter-University Centre for Astronomy & Astrophysics (IUCAA), has created a high frame-rate movie of a growing black hole system at a level of detail never seen before.
